UK Edition
AdvertiseSubmit Company
Pharma JournalEvidence-Based Pharmaceutical Intelligence
CLINICAL RESEARCH

TFP Fertility

Specialist fertility clinics across Europe

TFP Fertility logo

TFP Fertility

Clinical ResearchLondon, United Kingdom

Specialist fertility clinics across Europe

Visit WebsiteContact Company

About TFP Fertility

TFP Fertility is one of Europe's largest networks of fertility clinics, operating across the United Kingdom, Germany, Austria, Switzerland, and the Czech Republic. Founded in 2017 through the merger of established regional fertility groups, the network has grown to encompass dozens of clinics offering patients consistent, evidence-based reproductive care across national borders.

The group's clinical offering centres on IVF and assisted reproduction, including intrauterine insemination, egg freezing, donor programmes, and preimplantation genetic testing. Specialist services extend to fertility preservation for patients facing medical treatments that may affect future fertility, and to same-sex couples and single parents seeking donor-assisted pathways.

A defining feature of the TFP model is its integration of clinical expertise with a patient-centred care philosophy, supported by dedicated counselling and nursing teams at each site. The network invests in shared research and quality standards across its clinics, allowing outcomes data and clinical protocols to be benchmarked and improved across borders. This multi-country structure gives patients access to a broad range of consultants and laboratory technologies while remaining within a unified clinical governance framework.

TFP Fertility operates as part of the wider TFP fertility group, which is backed by institutional investment and continues to expand its European footprint through acquisition and organic growth. The group's scale allows it to attract senior reproductive medicine specialists and to maintain laboratory accreditation to high national and international standards in each market it serves.

Further information is available at tfp-fertility.com.

Areas of Expertise

Assisted ReproductionEgg FreezingFertility PreservationIVFPreimplantation Genetic TestingReproductive Medicine

Services & Capabilities

Assisted ReproductionEgg FreezingFertility PreservationIVFPreimplantation Genetic TestingReproductive Medicine
Similar Companies

More in Clinical Research

A

Affinity

Combining mobile nursing, teletrials and a dedicated oncology unit, Affinity Clinical Research Services brings clinical research capability directly to patients across Perth and the wider Australian continent. Operating from Doubleview in Western Australia and from a research facility within Hollywood Private Hospital Medical Centre, the organisation serves pharmaceutical sponsors, biotechnology companies and independent investigators seeking a flexible, patient-centred site partner. Affinity's service model covers the full research lifecycle, from protocol development and site feasibility through participant recruitment, data collection and publication support. The company's direct-to-patient and mobile trial services reduce the burden on participants who would otherwise be unable to access a fixed trial site, extending sponsor reach into regional and rural populations. This approach aligns with ICH-GCP guidelines and is adapted to the specific needs of each patient group and study design. The dedicated oncology division, Affinity Oncology, was established in 2016 and draws on clinical staff with more than a decade of experience in cancer trials. On-site resources include PET/CT imaging, a compounding pharmacy and a chemotherapy infusion suite, allowing complex oncology studies to run without reliance on third-party facilities. Beyond oncology, Affinity supports studies across a broad range of therapeutic areas and can assist private investigators running sponsor-initiated or investigator-initiated research. Further information is available at affinityresearch.com.au.

View profile
C

CREATE Fertility

CREATE Fertility is the UK's leading provider of natural and mild IVF, built on the principle that stimulating fewer eggs and working with the body's natural cycle can deliver strong outcomes while reducing the physical and financial burden on patients. Founded by Professor Geeta Nargund, CREATE has challenged the conventions of conventional high-stimulation IVF since its establishment, placing patient welfare and evidence-based practice at the centre of its clinical model.Operating across a network of clinics in London and other UK cities, CREATE offers a tiered approach to fertility treatment. Its Natural IVF and Mild Stimulation IVF protocols are designed to collect a smaller number of high-quality eggs, reducing the need for heavy hormonal medication. Alongside these, the clinic provides reproductive health assessments, fertility preservation (egg and embryo freezing), donor egg programmes, and diagnostic investigations for both female and male fertility.CREATE is regulated by the Human Fertilisation and Embryology Authority (HFEA), the UK statutory body that oversees all licensed fertility clinics. The clinic publishes its success rates through HFEA data, giving prospective patients transparent, independently verified benchmarks.Professor Nargund's broader influence extends into global reproductive health policy, and CREATE has been associated with efforts to make IVF more accessible and less medically intensive. The clinic's model has attracted attention from clinicians and patient advocates internationally as a lower-intervention alternative to conventional protocols.Further information is available at createfertility.co.uk.

View profile
A

ACROSS Global

Rather than operating as a single centralised CRO, ACROSS Global Alliance is built on an alliance model that connects experienced local partners across more than 90 countries into a unified clinical trial delivery network. This structure allows sponsors to access genuine in-market expertise, regulatory knowledge, and cultural understanding at each site, rather than relying on generalist staff deployed from a central office. Clinical Trial Management Across Markets The alliance covers the full trial lifecycle, encompassing study design, site selection, patient recruitment, trial execution, specialised diagnostics, and patient-centric care services. Because each local partner operates within their own established regulatory environment, ACROSS Global is positioned to support complex, multi-country studies with greater agility than traditional CRO models permit. The framework is designed to reduce costs and accelerate timelines without sacrificing quality or compliance standards. Who ACROSS Global Serves Sponsors ranging from large pharmaceutical companies to emerging biotech organisations and academic institutions use the ACROSS Global network to enter new markets or scale existing programmes. The cost-effective structure is particularly relevant for organisations managing defined budgets across geographically dispersed studies, where local knowledge directly affects recruitment speed and site performance. The proprietary technology platform supports coordination across the partner network, providing visibility and consistency throughout each programme. Further information is available at across.global.

View profile
AdvertisementTeksyte LTD

List Your Company

Showcase your company to thousands of pharma professionals.

Submit Listing

Advertise With Us

Reach decision-makers in the pharmaceutical industry.

Learn More

We use cookies and analytics to understand how the site is used and to keep the service free. Choose Accept All to allow this, or Essential Only to use just the cookies we need to keep the site working. You can change your choice any time in our Cookie Policy